tiletamine hydrochloride has been researched along with Urinary Bladder Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Cheng, F; Rao, T; Ruan, Y; Song, H; Xia, Y; Yu, W; Zhao, S; Zhu, S | 1 |
| Kung, ML; Lee, HT; Li, CC; Li, WM; Wei, YC; Wu, WJ; Wu, YC; Yang, JC; Yeh, BW; Yu, LE | 1 |
| Horiguchi, Y; Kanai, K; Kikuchi, E; Kodaira, K; Kosugi, M; Matsumoto, K; Miyajima, A; Nakagawa, K; Oya, M; Suzuki, E; Tachibana, M; Umezawa, K | 1 |
| Horiguchi, Y; Kuroda, K; Murai, M; Nakashima, J; Umezawa, K | 1 |
1 review(s) available for tiletamine hydrochloride and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Cyclohexanones; Humans; NF-kappa B; Urinary Bladder Neoplasms | 2003 |
3 other study(ies) available for tiletamine hydrochloride and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers; Cell Cycle; Cell Line, Tumor; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Urinary Bladder Neoplasms | 2021 |
The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy.
Topics: AC133 Antigen; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Cyclohexanones; Flavones; Humans; Molecular Structure; Neoplastic Stem Cells; Retrospective Studies; Urinary Bladder Neoplasms; Urothelium | 2020 |
Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.
Topics: Animals; Benzamides; Cyclohexanones; Cytokines; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2010 |